Literature DB >> 24714555

Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.

Francesca Crovetto1, Francesc Figueras, Stefania Triunfo, Fatima Crispi, Victor Rodriguez-Sureda, Anna Peguero, Carmen Dominguez, Eduard Gratacos.   

Abstract

OBJECTIVE: To explore the predictive role of angiogenic factors for the prediction of early and late preeclampsia (PE) in the first trimester.
METHODS: A nested case-control study, within a cohort of 5,759 pregnancies, including 28 cases of early, 84 of late PE (cut-off 34 weeks) and 84 controls. Maternal characteristics, mean blood pressure (MAP), uterine artery (UtA) Doppler (11-13 weeks), vascular endothelial growth factor, placental growth factor (PlGF), soluble Fms-like tyrosine kinase-1 (sFlt-1) and soluble endoglin (8-11 weeks) were measured/recorded. All parameters were normalized by logarithmic transformation; logistic regression analysis was used to predict PE.
RESULTS: For early PE, significant contributions were chronic hypertension, previous PE, MAP, UtA Doppler, PlGF and sFlt-1. A model including these predictors achieved detection rates (DR) of 77.8 and 88.9% for 5 and 10% false-positive rates (FPR), respectively (AUC 0.958; 95% CI 0.920-0.996). For late PE, significant contributions were provided by body mass index, previous PE, UtA Doppler, PlGF and sFlt-1. The model including these factors achieved DR of 51.2 and 69% at 5 and 10% FPR, respectively (AUC 0.888; 95% CI 0.840-0.936).
CONCLUSIONS: Among angiogenic factors, not only PlGF but also sFlt-1 substantially improve the prediction for early and late PE. The data need confirmation in larger studies.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24714555     DOI: 10.1159/000358302

Source DB:  PubMed          Journal:  Fetal Diagn Ther        ISSN: 1015-3837            Impact factor:   2.587


  6 in total

Review 1.  Metformin, the aspirin of the 21st century: its role in gestational diabetes mellitus, prevention of preeclampsia and cancer, and the promotion of longevity.

Authors:  Roberto Romero; Offer Erez; Maik Hüttemann; Eli Maymon; Bogdan Panaitescu; Agustin Conde-Agudelo; Percy Pacora; Bo Hyun Yoon; Lawrence I Grossman
Journal:  Am J Obstet Gynecol       Date:  2017-06-12       Impact factor: 8.661

2.  Predictive accuracy of the first trimester Doppler scan: a meta-study.

Authors:  Naira Roland Matevosyan
Journal:  Wien Med Wochenschr       Date:  2015-06-16

Review 3.  Vascular Dysfunction in Mother and Offspring During Preeclampsia: Contributions from Latin-American Countries.

Authors:  Fernanda Regina Giachini; Carlos Galaviz-Hernandez; Alicia E Damiano; Marta Viana; Angela Cadavid; Patricia Asturizaga; Enrique Teran; Sonia Clapes; Martin Alcala; Julio Bueno; María Calderón-Domínguez; María P Ramos; Victor Vitorino Lima; Martha Sosa-Macias; Nora Martinez; James M Roberts; Carlos Escudero
Journal:  Curr Hypertens Rep       Date:  2017-10-06       Impact factor: 5.369

4.  Can we measure the spiral and uterine artery blood flow by real-time sonography and Doppler indices to predict spontaneous miscarriage in a normal-risk population?

Authors:  Mehmet Burak Özkan; Elif Ozyazici; Baris Emiroglu; Enis Özkara
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

5.  Systematic review of prediction models for gestational hypertension and preeclampsia.

Authors:  Edward Antwi; Mary Amoakoh-Coleman; Dorice L Vieira; Shreya Madhavaram; Kwadwo A Koram; Diederick E Grobbee; Irene A Agyepong; Kerstin Klipstein-Grobusch
Journal:  PLoS One       Date:  2020-04-21       Impact factor: 3.240

6.  Diagnostic Performance of First Trimester Screening of Preeclampsia Based on Uterine Artery Pulsatility Index and Maternal Risk Factors in Routine Clinical Use.

Authors:  Max Mönckeberg; Valentina Arias; Rosario Fuenzalida; Santiago Álvarez; Victoria Toro; Andrés Calvo; Juan P Kusanovic; Lara J Monteiro; Manuel Schepeler; Jyh K Nien; Jaime Martinez; Sebastián E Illanes
Journal:  Diagnostics (Basel)       Date:  2020-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.